Literature DB >> 15738755

The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: a retrospective follow-up study.

Hans Mulder, Frederik W Wilmink, Tim L Beumer, Wim J Tamminga, Jaap N Jedema, Antoine C G Egberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15738755     DOI： 10.1097/01.jcp.0000155832.79777.b5

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

Review 1.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.

Authors:  Alice I Nichols; Kristen Focht; Qin Jiang; Sheldon H Preskorn; Cecelia P Kane
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.

Authors:  Monique J Bijl; Loes E Visser; Albert Hofman; Arnold G Vulto; Teun van Gelder; Bruno H Ch Stricker; Ron H N van Schaik
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

Review 4.  Do we need pharmacogenetics to personalize antidepressant therapy?

Authors:  Cristina Lanni; Marco Racchi; Stefano Govoni
Journal:  Cell Mol Life Sci       Date:  2012-12-28       Impact factor: 9.261

5.  Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.

Authors:  J Winner; J D Allen; C Anthony Altar; A Spahic-Mihajlovic
Journal:  Transl Psychiatry       Date:  2013-03-19       Impact factor: 6.222

6.  CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression.

Authors:  Kyu-Man Han; Hun Soo Chang; In-Kwang Choi; Byung-Joo Ham; Min-Soo Lee
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

7.  Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.

Authors:  Anick Bérard; Andrea Gaedigk; Odile Sheehy; Christina Chambers; Mark Roth; Pina Bozzo; Diana Johnson; Kelly Kao; Sharon Lavigne; Lori Wolfe; Dee Quinn; Kristen Dieter; Jin-Ping Zhao
Journal:  Front Pharmacol       Date:  2017-07-17       Impact factor: 5.810

8.  Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.

Authors:  Young Sup Woo; Roger S McIntyre; Jung-Bum Kim; Min-Soo Lee; Jae-Min Kim; Hyeon Woo Yim; Tae-Youn Jun
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.